Research location
Alkmaar
Netherlands
Advertisement
Research activity in Alkmaar
NetherlandsCureCurrent currently publishes aggregate city-level research activity for this location: 135 trials and 136 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Alkmaar
135 linked trials · page 1 of 3A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFNCT07761117 · 2026-08-24 · 1 site observation
RECRUITING
The SELEQT-HF (SELEnium and CoQ10 NuTrition for Heart Failure) Study Will Evaluate the Effect of Adding Selenium/and coQ10 on Top of Standard HF Therapy in Patients With HF and Will do so Using a Pragmatic, Registry Based Randomized Controlled Trial in the Netherlands.NCT07234422 · 2026-05-04 · 1 site observation
RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 1 site observation
RECRUITING
Prospective Data Collection Initiative on Thoracic MalignanciesNCT06996249 · 2025-08-15 · 1 site observation
RECRUITING
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation
RECRUITING
Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast CancerNCT07146295 · 2025-04-18 · 1 site observation
RECRUITING
OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating LymphocytesNCT06476119 · 2025-04-15 · 1 site observation
RECRUITING
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLCNCT06627647 · 2024-11-27 · 1 site observation
RECRUITING
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)NCT06692738 · 2024-11-18 · 1 site observation
RECRUITING
Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate CancerNCT07260435 · 2024-02-20 · 1 site observation
RECRUITING
COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO StudyNCT05301881 · 2023-04-17 · 1 site observation
RECRUITING
High-Risk prostatE Cancer radiatiOn Versus surgERyNCT05931419 · 2023-02-16 · 1 site observation
RECRUITING
The "Global Paradise System" RegistryNCT05027685 · 2022-01-13 · 1 site observation
RECRUITING
Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast CancerNCT04486495 · 2020-07-16 · 1 site observation
RECRUITING
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or ObesityNCT07861100 · 2026-10-26 · 1 site observation
NOT_YET_RECRUITING
BIO|MASTER.CSP StudyNCT06620237 · 2024-10-04 · 1 site observation
ACTIVE_NOT_RECRUITING
A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of ExacerbationsNCT06529419 · 2024-08-30 · 1 site observation
COMPLETED
DUTCH Weight Control in Atrial Fibrillation StudyNCT06184633 · 2024-07-21 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)NCT06472076 · 2024-06-10 · 1 site observation
ACTIVE_NOT_RECRUITING
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)NCT06383390 · 2024-04-30 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.NCT06268873 · 2024-03-29 · 1 site observation
ACTIVE_NOT_RECRUITING
Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast CancerNCT05503108 · 2023-03-17 · 1 site observation
SUSPENDED
The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKDNCT05374291 · 2022-11-08 · 1 site observation
ENROLLING_BY_INVITATION
SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)NCT05392608 · 2022-06-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsNCT05166889 · 2022-01-03 · 1 site observation
COMPLETED
REsponsible roLl-out of E-heAlth Through Systematic Evaluation - Heart Failure StudyNCT05654961 · 2022-01-01 · 1 site observation
UNKNOWN
Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular DiseaseNCT04915755 · 2021-06-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Prospective Observational Study of Filgotinib in Subjects With Rheumatoid ArthritisNCT04871919 · 2021-05-11 · 1 site observation
ACTIVE_NOT_RECRUITING
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)NCT04509674 · 2020-12-16 · 1 site observation
COMPLETED
Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the NetherlandsNCT03783429 · 2020-07-01 · 1 site observation
COMPLETED
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney DiseaseNCT03819153 · 2019-06-17 · 1 site observation
COMPLETED
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)NCT03929679 · 2019-05-28 · 1 site observation
COMPLETED
Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 StudyNCT03820063 · 2019-02-27 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Test Radium-223 With Docetaxel in Patients With Prostate CancerNCT03574571 · 2018-06-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.NCT03361969 · 2018-04-16 · 1 site observation
COMPLETED
INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice DesignNCT03467425 · 2018-04-11 · 1 site observation
COMPLETED
Study to Investigate CSL112 in Subjects With Acute Coronary SyndromeNCT03473223 · 2018-03-21 · 1 site observation
COMPLETED
Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)NCT03345407 · 2017-11-28 · 1 site observation
TERMINATED
Brevera™ Breast Biopsy System Data Collection StudyNCT03456583 · 2017-11-20 · 1 site observation
COMPLETED
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast CancerNCT03425838 · 2017-11-09 · 1 site observation
ACTIVE_NOT_RECRUITING
A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart FailureNCT03152552 · 2017-07-25 · 1 site observation
TERMINATED
Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With DocetaxelNCT03295565 · 2017-05-07 · 1 site observation
COMPLETED
Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)NCT03034967 · 2017-04-25 · 1 site observation
COMPLETED
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy RegistryNCT03075215 · 2017-04-14 · 1 site observation
COMPLETED
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)NCT03040999 · 2017-04-05 · 1 site observation
COMPLETED
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation
TERMINATED
Management of Low-risk (Grade I and II) DCISNCT02492607 · 2017-02-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MINCT02924727 · 2016-12-09 · 1 site observation
COMPLETED
A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled AsthmaNCT02924688 · 2016-10-13 · 1 site observation
COMPLETED
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair AnomaliesNCT02854436 · 2016-08-31 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.